OS Therapies: Regulatory Momentum for Herlystic Supports Continued Buy Rating with Unchanged $6 Price Target
at www.tipranks.com (Fri, 25-Sep 11:55 AM)
Analysts Offer Insights on NA Companies: OS Therapies Incorporated (OSTX) and Axalta Coating Systems (AXTA)
at www.tipranks.com (Mon, 21-Sep 10:30 AM)
OSTX Gains FDA Alignment on Phase 3 Adaptive Design as MHRA Leads Project Orbis for OST-HER2
Market Chameleon (Thu, 17-Sep 10:26 AM)
